WEBINAR ON DEMAND
Duration: 1 hour
Technological developments have unlocked enormous potential in the world of preclinical drug development, but the industry is struggling to take full advantage of these new possibilities. Drug development pipelines can still take years or even decades, along with millions of dollars of investment, with no guarantee of success or return on investment. New technologies provide mountains of new data, but human scientists simply aren’t capable of handling that volume of data in an efficient way.
In this webinar, drug discovery experts Imran Khan (Bristol Myers Squibb) and Jorge Garcia Fortanet (DEM Biopharma) join AI expert Jim Corson (Enthought) to discuss:
Thank you for your interest in the webinar! Check your inbox for an email with instructions on viewing the on-demand presentation.Download Now
Enter the 6 digit code sent to your mobile number
Click on Resend the verification code again